Information Provided By: 
Fly News Breaks for March 2, 2018
DPLO
Mar 2, 2018 | 05:29 EDT
Deutsche Bank analyst Glen Santangelo upgraded Diplomat Pharmacy to Buy while trimming his price target for the shares to $28 from $29. The recent pullback in the shares is "too big to ignore," Santangelo tells investors in a research note. He recommends using the selloff in the shares as a buying opportunity.
News For DPLO From the Last 2 Days
There are no results for your query DPLO
